USPTO serial 99167616
OTI
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEEL, ALYSSA PALADINO
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with OTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sean P McConnell
Sean P McConnell Troutman Pepper Locke LLPEighteenth and Arch Streets3000 Two Logan SquarePhiladelphia, PA 19103-2799Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use; Scientific research kits for human and animal metabolites sample collection, stabilization, transportation and preparation consisting primarily of a preserving solution and specially designed collection receptacle to collect multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid and analysis or labelling of protein; Chemical preservatives for scientific and research purposes used to optimize the stability of biological samples and bodily fluid specimens during storage and transport to testing facilities; Kits comprising a preserving solution and specially designed collection tube used to optimally collect, stabilize, preserve, transport and extract analytes, namely, nucleic acids, proteins, and metabolites from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum and other bodily fluids extracted or collected from humans and animals all of the foregoing for scientific and research purposes; Reagents for research or scientific purposes used to collect, stabilize, transport and prepare analytes, namely, nucleic acids, proteins, and metabolites from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids | ACTIVE | — |
| 005 | Medical diagnostic kits consisting primarily of antibodies, antigens, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of biological samples and bodily fluids for use in disease detection; Medical diagnostic kits comprising agents, preparations, and substances for medical purposes, in particular, standards, reagents and controls used in measuring performance or quality of a medical diagnostic assay for testing blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids; Chemical stabilizing preparations for medical diagnostic purposes for preserving biological samples and bodily fluid specimens during transportation and storage to medical testing facilities; Medical diagnostic reagents and assays for testing biological samples and bodily fluids for pathogens; Chemical preservatives for medical diagnosis purposes to optimize the stability of biological samples and bodily fluid specimens during storage and transport to medical testing facilities; Diagnostic kits and devices comprised of medical diagnostic reagents and assays for testing analytes, namely, nucleic acids, and proteins in biological samples and bodily fluids for use in pathogen and disease detection; Kits comprising a preserving solution and specially designed collection tube used to optimally collect, stabilize, preserve, transport and extract analytes, namely, nucleic acids, proteins, and metabolites from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum and other bodily fluids extracted or collected from humans and animals all of the foregoing for clinical, medical and medical diagnostic use; Medical reagents used to collect, stabilize, transport and prepare analytes, namely, nucleic acids, proteins, and metabolites from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids; Medical reagents used to collect, stabilize, transport and prepare analytes, namely, nucleic acids, proteins, metabolites from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids; Medical research and diagnostic kits for nucleic acid sample collection, stabilization, and transportation and preparation comprising a preserving solution and specially designed collection receptacle to collect multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Medical diagnostic kits for human and animal metabolites sample collection, stabilization, transportation and preparation consisting primarily of a specifically designed collection receptacle and also containing a preserving solution to collect multiple sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Urine testing instruments in the nature of test strips, a preserving solution and specially designed collection receptacle for medical diagnostic purposes; Medical diagnostic kits comprising a preserving solution and specially designed collection receptacle used to collect, store, transport and prepare nucleic acids from multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood | ACTIVE | — |
| 009 | Scientific laboratory research equipment not for medical purposes, namely, kits for nucleic acid sample collection, stabilization, transportation and preparation comprising a preserving solution and specially designed collection receptacle to collect multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Scientific laboratory research equipment not for medical purposes, namely, saliva, tissue, sputum, mucus and mucosa cells, or blood collection kits comprising one or more of a preserving solution, a sponge, and a specially designed collection tube used to collect, stabilize, transport and purify said samples; Scientific laboratory research equipment not for medical purposes, namely, kits comprising a preserving solution and specially designed collection receptacle used to collect, store, transport and prepare nucleic acids from multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Scientific laboratory research equipment not for medical purposes, namely, nucleic-acid extraction kits used to optimally extract and optimize nucleic acids from multiple bodily tissue and fluid sample types containing one or more of the following: sample tubes, spin columns, chromatographic columns, vials, plastic bags, bottles, magnetic beads, glass beads, nucleic-acid binding beads, pipettes, reagents, buffer solution, binding buffer, elution buffer, wash buffer, lysis buffer, laboratory plasticware, instructions, and general laboratory consumables | ACTIVE | — |
| 010 | Kits for nucleic acid sample collection, stabilization, and transportation comprising a preserving solution and specially designed collection receptacle to collect multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood, all for medical research, medical, medical clinical or medical diagnostic purposes; Saliva, tissue, sputum, mucus and mucosa cells, or blood collection kits comprising one or more of a preserving solution, a sponge, and a specially designed collection tube used to collect, stabilize, transport and purify said samples for medical research, medical, medical clinical or medical diagnostic purposes; Kits used to collect, preserve and transport DNA samples from subjects' saliva for medical identification and testing purposes consisting of specially designed collection tube containers and a preserving solution; Medical research and diagnostic kits comprising a preserving solution and specially designed collection receptacle used to collect, store, and transport nucleic acids from multiple bodily tissue and fluid sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; Medical diagnostic equipment, namely, nucleic-acid extraction kits used to optimally extract and optimize nucleic acids from multiple bodily tissue and fluid sample types containing one or more of the following: sample tubes, spin columns, chromatographic columns, vials, plastic bags, bottles, magnetic beads, glass beads, nucleic-acid binding beads, pipettes, reagents, buffer solution, binding buffer, elution buffer, wash buffer, lysis buffer, laboratory plasticware, instructions, and general laboratory consumables | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OraSure Technologies, Inc.
- Other trademarks owned by OraSure Technologies, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named OTI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 29, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 29, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 29, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 29, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 29, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 29, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 29, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 29, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 18, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 18, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 18, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 18, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 26, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 26, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2025 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 12, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 2, 2025 | NWAP | NEW APPLICATION ENTERED | — |